According to Summit Therapeutics 's latest financial reports the company's total assets are A$0.69 Billion. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2024-12-31 | A$0.70 B | 135.08% |
2023-12-31 | A$0.29 B | -69.48% |
2022-12-31 | A$0.97 B | 524.11% |
2021-12-31 | A$0.15 B | 17.32% |
2020-12-31 | A$0.13 B | |
2019-01-31 | A$0.14 B | 5.37% |
2018-01-31 | A$0.13 B | 75.8% |
2017-01-31 | A$77.62 M | 8.18% |
2016-01-31 | A$71.75 M | 26.84% |
2015-01-31 | A$56.57 M | 150.66% |
2014-01-31 | A$22.57 M | 115.31% |
2013-01-31 | A$10.48 M | 15.47% |
2012-01-31 | A$9.07 M | -29.71% |
2011-01-31 | A$12.91 M | -61.2% |
2010-01-31 | A$33.29 M | -24.19% |
2009-01-31 | A$43.91 M | -71.53% |
2008-01-31 | A$0.15 B | 31.21% |
2007-01-31 | A$0.11 B | 91.39% |
2006-01-31 | A$61.41 M | -6.03% |
2005-01-31 | A$65.36 M |